Linezolid-associated serotonin syndrome: What we can learn from cases reported so far

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 6, 2005, Pages 1176-1178

  Morales Molina, José Antonio ^a   Antonio, Javier Mateu de ^a   Marín Casino, Mónica ^a   Grau, Santiago ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

Citalopram; Oxazolidinones; Serotonin uptake inhibitors

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; FENTANYL; FLUOXETINE; LINEZOLID; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CORRELATION ANALYSIS; DATA BASE; DRUG HALF LIFE; HIGH RISK POPULATION; HUMAN; LUNG INFECTION; MENTAL DISEASE; OSTEOMYELITIS; PANCREATITIS; PROSTHESIS INFECTION; SEROTONIN SYNDROME; SKIN INFECTION; SOFT TISSUE INFECTION; SYMPTOMATOLOGY;

ACETAMIDES; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD, PRESCHOOL; CITALOPRAM; FEMALE; HALF-LIFE; HUMANS; MALE; MIDDLE AGED; OXAZOLIDINONES; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 29444456394     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki368     Document Type: Article

References (17)

1. Rubinstein E, Isturiz R, Standiford HC et al. Worldwide assessment of linezolid's clinical safety and tolerability: Comparator-controlled phase III studies. Antimicrob Agents Chemother 2003; 47: 1824-31.
2. Boyer EW, Shannon M. Current concepts: The serotonin syndrome. N Engl J Med 2005; 352: 1112-20.
3. Aga VM, Barklage NE, Jefferson JW, Linezolid, a monoamine oxidase inhibiting antibiotic, and antidepressants. J Clin Psychiatry 2003; 64: 609-11.
4. Ferry T, Ponceau S, Simon M et al. Possibly linezolid-induced peripheral and central neurotoxicity: Report of four cases. Infection 2005; 33: 151-4.
5. Lavery S, Ravi H, McDaniel WW et al. Linezolid and serotonin syndrome. Psychosomatics 2001; 42: 432-4.
6. Wigan CL, Goetz MS. Serotonin syndrome and linazolid. Clin Infect Dis 2002; 34: 1651-2.
7. Hachem RY, Hicks K, Huen A et al. Myelosuppression and sarotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients. Clin Infect Dis 2003; 37: E8-11.
8. Bernard L, Stern R, Law D et al. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin Infect Dis 2003; 36: 1197.
9. Jones SL, Athan E, O'Brien D. Serotonin syndrome due to co-administration of linezolid and venlafaxine. J Antimicrob Chemother 2004; 54: 289-90.
10. Thomas CR, Rosenberg M, Blythe V et al. Serotonin syndrome and linezolid. J Am Acad Child Adolesc Psychiatry 2004; 43: 790.
11. Tahir N. Serotonin Syndrome as a consequence of drug-resistant infections: An interaction between linezolid and citalopram. J Am Med Dir Assoc 2004; 5: 111-3.
12. Bergeron L, Boule M, Perrault S. Serotonin toxicity associated with concomitant use of linezolid. Ann Pharmacother 2005; 39: 956-61.
13. Morales N, Vermette H. Serotonin syndrome associated with linezolid treatment after discontinuation of fluoxetine. Psychosomatics 2005; 46: 274-5.
14. Morales-Molina JA, Mateu-de Antonio J, Grau Cerrato S et al. Probable serotonin syndrome by interaction of amitriptiline, paroxetine and linezoild. Farm Hosp 2005; 29: 292-3.
15. Thummel KE, Shen DD. Design and optimization of dosage regimens: pharmacokinetic data. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th edn. NY: McGraw-Hill, 2001; 1917-2024.
16. Sheline Y, Mintun MA, Moerlein SM et al. Greater loss of 5-HT2A receptors in midlife than in late life. Am J Psychiatry 2002; 159: 430-5.
17. Guyton AC, Hall JE. Organization of the nervous system; basic functions of synapses and transmitter substances, In: Guyton AC, Hall JE, eds. Textbook of Medical Physiology, 10th edn. Philadelphia: Interamericana McGraw-Hill, 2001; 525.